| 摘要 |
The invention is directed to the use of Diflunisal for the preparation of a medicament for the treatment of cancer, wherein the medicament is adapted for administration so that a molecular ratio of 4:1 to 6:1 of interstitial Diflunisal to interstitial albumin is provided. |
